Paper39803293
The Potential of the Probiotic Isolate Lactobacillus plantarum SS18-50 to Prevent Colitis in Mice.
Wang D and 3 others. Food Sci Nutr, 2025. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Potential of the Probiotic Isolate Lactobacillus plantarum SS18-50 to Prevent Colitis in Mice. Papers, record 39803293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39803293
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Potential of the Probiotic Isolate Lactobacillus plantarum SS18-50 to Prevent Colitis in Mice.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,752,563 | Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition. | Mol Nutr Food Res | 2017 | https://conductscience.org/library/papers/28752563 | PubMed |
| 2 | 26,645,352 | Specific probiotic dietary supplementation leads to different effects during remission and relapse in murine chronic colitis. | Benef Microbes | 2016 | https://conductscience.org/library/papers/26645352 | PubMed |
| 3 | 33,242,708 | Ameliorative effects of alginate oligosaccharide on tumour necrosis factor-α-induced intestinal epithelial cell injury. | Int Immunopharmacol | 2020 | https://conductscience.org/library/papers/33242708 | PubMed |
| 4 | 30,216,448 | Lactobacillus reuteri F-9-35 Prevents DSS-Induced Colitis by Inhibiting Proinflammatory Gene Expression and Restoring the Gut Microbiota in Mice. | J Food Sci | 2018 | https://conductscience.org/library/papers/30216448 | PubMed |
| 5 | 38,833,212 | A comparative evaluation of the kefir yeast Kluyveromyces marxianus A4 and sulfasalazine in ulcerative colitis: anti-inflammatory impact and gut microbiota modulation. | Food Funct | 2024 | https://conductscience.org/library/papers/38833212 | PubMed |
| 6 | 15,533,892 | The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. | Br J Pharmacol | 2004 | https://conductscience.org/library/papers/15533892 | PubMed |
| 7 | 24,993,179 | Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis. | Int J Mol Med | 2014 | https://conductscience.org/library/papers/24993179 | PubMed |
| 8 | 31,434,172 | Role of Probiotics in Human Gut Microbiome-Associated Diseases. | J Microbiol Biotechnol | 2019 | https://conductscience.org/library/papers/31434172 | PubMed |
| 9 | 19,711,178 | Evaluation of anti-colitic effect of lactic acid bacteria in mice by cDNA microarray analysis. | Inflammation | 2009 | https://conductscience.org/library/papers/19711178 | PubMed |
| 10 | 28,653,751 | Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. | Aliment Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28653751 | PubMed |
| 11 | 22,442,342 | Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. | Exp Biol Med (Maywood) | 2012 | https://conductscience.org/library/papers/22442342 | PubMed |
| 12 | 38,227,799 | An Inflammatory Bowel Diseases Integrated Resources Portal (IBDIRP). | Database (Oxford) | 2024 | https://conductscience.org/library/papers/38227799 | PubMed |
| 13 | 33,405,352 | Mucosal IL-10 and IL-10 receptor expression patterns in paediatric patients with ulcerative colitis. | Int J Exp Pathol | 2021 | https://conductscience.org/library/papers/33405352 | PubMed |
| 14 | 33,737,918 | Therapeutic Effects of Probiotic Minas Frescal Cheese on the Attenuation of Ulcerative Colitis in a Murine Model. | Front Microbiol | 2021 | https://conductscience.org/library/papers/33737918 | PubMed |
| 15 | 36,669,152 | Lactiplantibacillus plantarum BW2013 protects mucosal integrity and modulates gut microbiota of mice with colitis. | Can J Microbiol | 2023 | https://conductscience.org/library/papers/36669152 | PubMed |
| 16 | 8,350,599 | Clinicopathologic study of dextran sulfate sodium experimental murine colitis. | Lab Invest | 1993 | https://conductscience.org/library/papers/8350599 | PubMed |
| 17 | 15,875,451 | Inflammatory bowel disease and endothelin-1: a review. | Crit Care Nurs Q | 2005 | https://conductscience.org/library/papers/15875451 | PubMed |
| 18 | 37,573,077 | Ulcerative colitis. | Lancet | 2023 | https://conductscience.org/library/papers/37573077 | PubMed |
| 19 | 28,233,848 | Spray-drying process preserves the protective capacity of a breast milk-derived Bifidobacterium lactis strain on acute and chronic colitis in mice. | Sci Rep | 2017 | https://conductscience.org/library/papers/28233848 | PubMed |
| 20 | 24,010,775 | Dextran sodium sulfate inhibits the activities of both polymerase and reverse transcriptase: lithium chloride purification, a rapid and efficient technique to purify RNA. | BMC Res Notes | 2013 | https://conductscience.org/library/papers/24010775 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,220,421 | Therapeutic Potential Targeting Gut Microbiota Modulation With Emphasis on Lactobacillus spp. in Common Metabolic Disorders: A Systematic Review. | Scientifica (Cairo) | 2025 | https://conductscience.org/library/papers/41220421 | PubMed |
| 40,920,195 | The ameliorative effect of Lactiplantibacillus plantarum SCS2 on DSS-induced murine colitis. | Arch Microbiol | 2025 | https://conductscience.org/library/papers/40920195 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39803293
GET https://conductscience.org/api/papers/v1/39803293/references?page=2